相关实验视频

Updated: Jul 27, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

肺癌中的生殖线EGFR突变 (综述)

Minghui Liu¹, Xiaoyu Niu¹, Hongyu Liu²

¹Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Heping, Tianjin 300052, P.R. China.

Oncology letters

|June 5, 2023

概括

家庭肺癌可能与遗传的表皮生长因子受体 (EGFR) 突变有关. 通过查和定期检查的早期检测可以帮助识别肺癌风险.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

肺癌是癌症死亡的主要原因之一.
家庭肺癌表明一种遗传倾向.
表皮生长因子受体 (EGFR) 突变是癌症发展的关键.

研究的目的:

要总结EGFR中常见的生殖基因突变.
详细介绍突变部位和潜在的治疗策略.
要突出生殖系突变在肺癌病因学中的作用.

主要方法:

对常见的EGFR生殖系突变 (T790M,V843I,R776H,P848L) 的文献综述.
分析突变部位和相关的治疗选择.
讨论与生殖系突变相互作用的环境和体质因素.

主要成果:

确定了常见的EGFR生殖基因突变:T790M,V843I,R776H和P848L.
关于特定突变位置及其临床影响的详细信息.
探索了生殖系突变,环境因素和体质事件之间的相互作用.

结论:

生殖系EGFR突变会增加肺癌的风险,特别是在环境暴露或二次体质突变时.
建议定期进行体检,以便早期检测.
倡导全人口生殖基因突变查,以积极主动地治疗肺癌.

关键词:

皮肤上生长因子受体.这是家族性肺癌.发生生殖线突变的生殖线突变.肺癌是一种肺癌.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

相关概念视频